Search results
Researcher discovers that endometriosis tricks the immune system in the same way cancer does
Medical Xpress· 4 hours agoTreatment options for those suffering from endometriosis are currently few, but research at Umeå University provides new opportunities to understand the disease. A new thesis answers the question ...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 3 days agoABBV-706 is an ADC targeting SEZ6, a transmembrane protein expressed in various solid tumours,...
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 2 days agoEtrumadenant is an investigational small molecule, selective dual antagonist of the A2a and A2b...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 6 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
Are You Getting Enough Iodine From Your Diet?
Mercola· 2 days agoUnfortunately, data collected by the U.S. National Health and Nutrition Examination Survey has revealed a significant drop in median urine iodine values.1 The median iodine level measured in ...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 6 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Molecular Assassins: How Azoles Cause Fungal Pathogens to Self-Destruct
SciTechDaily· 6 days agoNew research led by the University of Exeter shows that azole antifungals trigger self-destruction...
Exploring the potential of dietary phytochemicals in cancer prevention
Medical Xpress· 5 days agoCancer remains a significant global health challenge and is a leading cause of mortality worldwide....
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved...
Clearfield Progress· 3 days agoAfter rigorous evaluation by Scientific Program Committee and ASCO Leadership, LBL-024, a bispecific antibody independently developed by Leads Biolabs with global intellectual property rights ...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 4 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related